IP Library Granted Patent US 6,930,205
Granted Patent B2
US 6,930,205 · App. 10/740,543 · Granted Aug 16, 2005

Process for preparing aminostilbene derivatives

Assignee: Ajinomoto Co., Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,930,205
App. No.
10/740,543
Granted
Aug 16, 2005
Kind
B2
Abstract

The present invention relates to a novel process for preparing an aminostilbene derivative, which is important as an active component of anticancer drugs or an intermediate for preparation thereof, as well as methods of producing the same.

Claims (25)

1. A method for preparing an aminostilbene derivative of formula (2):

wherein each of R 1 , R 2 , R 3 and R 4 independently represents an alkyl group having 1-3 carbon atoms and the linking sites of OR 4 and NH 2 on the benzene ring are optional

comprising

reacting a nitrostilbene derivative represented by formula (1) with formic acid and/or a formate salt in the presence of a noble metal catalyst

wherein each of R 1 , R 2 , R 3 and R 4 independently represents an alkyl group having 1-3 carbon atoms and the linking sites of OR 4 and NO 2 on the benzene ring are optional.

2. The method of claim 1 , wherein said aminostilbene derivative is in the form of a salt.

3. The method of claim 1 , wherein at least one of R 1 , R 2 , R 3 and R 4 is a methyl group.

4. The method of claim 3 , wherein each of the R 1 , R 2 , R 3 and R 4 is respectively a methyl group.

5. The method of claim 1 , wherein OR 4 is linked at 4-position and the NO 2 and NH 2 are linked at 3-position on the benzene ring to the linking site of substituted vinyl group.

6. The method of claim 1 , wherein the noble metal catalyst is a platinum catalyst or a palladium catalyst.

7. The method of claim 6 , wherein the noble metal catalyst is a platinum catalyst.

8. The method of claim 6 , wherein the platinum catalyst is platinum on carbon and the palladium catalyst is palladium on carbon.

9. The method of claim 1 , wherein the formate salt is ammonium formate.

10. The method of claim 1 , wherein the aminostilbene derivative of formula (2) is (Z)-2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)vinyl]aniline or a salt thereof.

11. The method of claim 1 , wherein the nitrostilbene derivative represented by formula (1) is (Z)-3,4,4′,5-tetramethoxy-3′-nitrostilbene.

12. The method of claim 11 , wherein, said reacting is with a formate salt in the presence of a platinum catalyst.

13. The method of claim 6 , wherein the aminostilbene derivative of formula (2) is (Z)-2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)vinyl]aniline or a salt thereof.

14. The method of claim 6 , wherein the nitrostilbene derivative represented by formula (1) is (Z)-3,4,4′,5-tetramethoxy-3′-nitrostilbene.

15. The method of claim 1 , wherein the aminostilbene derivative of formula (2) is (Z)-2-methoxy-5-[2- (3,4,5 -trimethoxyphenyl)vinyl]aniline or a salt thereof, the nitrostilbene derivative represented by formula (1) is (Z)-3,4,4′,5-tetramethoxy-3′-nitrostilbene.

16. The method of claim 1 , further comprising isolating the aminostilbene derivative of formula (2) or a salt thereof by a method selected from the group consisting of extraction, crystallization, and chromatography.

17. The method of claim 1 , wherein the amount of the noble metal catalyst ranges from 0.1 to 10 mole % to the nitrostilbene derivative represented by formula (1).

18. The method of claim 1 , wherein the amount of the formic acid and/or a formate salt ranges from 200-700 mole % to the nitrostilbene derivative represented by formula (1).

19. The method of claim 1 , wherein the temperature of the reaction ranges from 0° C. to the boiling temperature of reaction mixture.

20. The method of claim 1 , wherein the aminostilbene derivative of formula (2) is (Z)-2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)vinyl]aniline or a salt of the same, the nitrostilbene derivative represented by formula (1) is (Z)-3,4,4′,5-tetramethoxy-3′-nitrostilbene, the formic acid and/or a formate salt is a formate salt, and the noble metal catalyst is a platinum catalyst.

21. The method of claim 1 , wherein the aminostilbene derivative of formula (2) is (Z)-2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)vinyl]aniline or a salt of the same, the nitrostilbene derivative represented by formula (1) is (Z)-3,4,4′,5-tetramethoxy-3′-nitrostilbene, the formic acid and/or a formate salt is a formate salt, and the noble metal catalyst is a palladium catalyst.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2016
From: AJINOMOTO CO., INC.
To: EA PHARMA CO., LTD.
Reel/Frame 039094/0087 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2004
From: YAMAMOTO, TAKASHI; MATSUEDA, HIROYUKI; NAITO, MASAKI; ARAI, ISAO; YATAGAI, MASANOBU
To: AJINOMOTO CO., INC.
Reel/Frame 015368/0993 →
Priority Claims (1)
JP 2001-190117 · Jun 22, 2001 · national
Continuity (2)
Continuation PCTJP020617400 · Jun 20, 2002
Related Publication 20040176642A1 · Sep 9, 2004